HONG KONG & NEW DELHI – Middle East respiratory syndrome (MERS) is in the spotlight across Asia, as researchers search for drugs to fight a virus many fear could be as devastating as SARS was in 2003.
LUCKNOW, India – An Indian government-funded drug research institute plans to set up a biopharma industry incubation center to attract entrepreneurs in northern and central India, areas that are home to a number of high-quality research laboratories but are in dire need of bioclusters.
LUCKNOW, India – An Indian government-funded drug research institute plans to set up a biopharma industry incubation center to attract entrepreneurs in northern and central India, areas that are home to a number of high-quality research laboratories but are in dire need of bioclusters.
NEW DELHI – With three new vaccines in the pipeline over the next two years – for viruses that are common in developing tropical countries – India-based Bharat Biotech International Ltd. (BBIL) continues to pursue its defining mantra of a $1-a-dose vaccine that is within the reach of people in poor countries.
NEW DELHI – With three new vaccines in the pipeline over the next two years – for viruses that are common in developing tropical countries – India-based Bharat Biotech International Ltd. (BBIL) continues to pursue its defining mantra of a $1-a-dose vaccine that is within the reach of people in poor countries.
